Nicole Bou Rjeily

4PUBLICATIONS
20CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)BiomechanicsMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Sep 19, 2025
Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls.

Andrea Salazar-Camelo, Lauren Vega, Yasser Fadlallah

|Mar 31, 2025
Accelerometry-Assessed Physical Activity and Circadian Rhythm to Detect Clinical Disability Status in Multiple Sclerosis: Cross-Sectional Study.

Nicole Bou Rjeily, Muraleetharan Sanjayan, Pratim Guha Niyogi

|Nov 09, 2023
Extended interval dosing of ocrelizumab in patients with multiple sclerosis is not associated with meaningful differences in disease activity.

Nicole Bou Rjeily, Kathryn C Fitzgerald, Ellen M Mowry

|Sep 12, 2023
Clinical and radiologic characteristics associated with multiple sclerosis misdiagnosis at a tertiary referral center in the United States.

Yujie Wang, Nicole Bou Rjeily, Jacqueline Koshorek

Pageof 1